Concepedia

Richard Sparks

RS

Statistics

Publications

43

Citations

4.8K

H-Index

30

Active since

1995

Affiliations

Incyte (United States)(Current)

Experimental Station

Vanderbilt University

Oak Ridge Associated Universities

Richard Sparks is an author at Incyte (United States) specializing in medicine, nuclear medicine, and radiation dosimetry.

Publications per year

1995–2025

43

Publications

43

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.

Michael G. Stabin, Richard Sparks, Eric A. Crowe · PubMed · 2005 · 1.4K citations

Medicine, Internal Medicine, Nuclear Medicine +14

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Xiangdong Liu, Niu Shin, Holly K. Koblish et al. · Blood · 2010 · 559 citations · Full text

Medicine, Immunology, Oncology +14

INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology

Eddy W. Yue, Richard Sparks, Padmaja Polam et al. · ACS Medicinal Chemistry Letters · 2017 · 296 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors

Holly K. Koblish, Michael Hansbury, Kevin Bowman et al. · Molecular Cancer Therapeutics · 2010 · 245 citations · Full text

Medicine, Oncology, Pharmacology +13

Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.

Gregory A. Wiseman, Ellen Kornmehl, Bryan R. Leigh et al. · PubMed · 2003 · 216 citations

Medicine, Nuclear Medicine, Oncology +17

1–5 of 43